SCHEMBL7548169

SCHEMBL7548169

CCCCOC(=O)NCC(O)OCc1ncccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ NPC1 O15118 5/20 0.49
▸ RAB9A P51151 5/20 0.49
▸ LMNA P02545 1/20 0.49
▸ GAA P10253 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ ACHE P22303 7/20 0.39
▸ HRH4 Q9H3N8 2/20 0.39
▸ HRH3 Q9Y5N1 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ STAT1 P42224 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ CASP1 P29466 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7545282 0.86 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ALMNAGAA
SCHEMBL15348811 0.72 GAA (0.64) SMN1; SMN2NPC1RAB9ALMNAGAA
SCHEMBL30475381 0.70 ACHE (0.56) GAAACHE
SCHEMBL31614616 0.70 ACHE (0.55) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL10580487 0.70 ACHE (0.55) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL7277280 0.70 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ALMNAGAA
SCHEMBL7552785 0.70 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9ALMNAGAA
SCHEMBL15738570 0.69 SMN1; SMN2 (0.92) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL8507123 0.69 HPGD (0.67) SMN1; SMN2RAB9AL3MBTL1ALDH1A1HPGD
SCHEMBL28522595 0.68 ACHE (0.56) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212301-A1 ARYLALKYLOXYALKYLAMINES AND ARYLALKYLTHIOALKYLAMINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NICOTINIC CHOLINERGIC RECEPTORS Targacept, Inc. (US) 2002-06-12 — — EP disclosed
WO-2001016107-A1 ARYLALKYLOXYALKYLAMINES AND ARYLALKYLTHIOALKYLAMINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NICOTINIC CHOLINERGIC RECEPTORS TARGACEPT, INC. (US) 2001-03-08 — — WO disclosed
Send feedback